Boston Scientific (BSX) Stock Analysis
This is a peer-relative look at Boston Scientific (BSX): its performance, risk, profitability, growth, financial strength, dividend, and valuation are each measured against its Health Care Equipment & Services peers, so every number reads in context rather than in isolation.
Company Profile
| Profile Item | BSX |
|---|---|
| Name | Boston Scientific Corp. |
| Country/Region | United States |
| GICS Sector | Health Care |
| GICS Industry Group | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment |
| Market Capitalization | 61.96 billion USD |
| Currency | USD |
| Exchange | NYSE |
| Listing Date | May 19, 1992 |
| Security Type | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | Current stock: BSX | Industry group median |
|---|---|---|
| Total Return (1Y) | -55.98% | 21.53% |
| Total Return (3Y, Annualized) | -5.05% | 9.81% |
| Total Return (5Y, Annualized) | 0.57% | -2.76% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | Current stock: BSX | Industry group median |
|---|---|---|
| Volatility (1Y, Annualized) | 40.16% | 50.93% |
| Beta (5Y) | 0.57 | 0.85 |
| Max Drawdown (5Y) | -61.55% | -70.34% |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | Current stock: BSX | Industry group median |
|---|---|---|
| Sharpe Ratio (1Y) | -1.50 | 0.34 |
| Sortino Ratio (1Y) | -1.80 | 0.54 |
Profitability
ROE (TTM)
Boston Scientific (BSX) posts ROE of 14.12%, roughly around the peer group’s normal range. Shareholders’ equity is producing a return that looks broadly typical for the industry.
BSX
Health Care Equipment & Services industry group
14.12%
Group distribution
- Max
- 47.61%
- Q3
- 14.36%
- BSX
- 14.12%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Largest peers
- ISRG
- 17.93%
- SYK
- 16.02%
- UNH
- 15.77%
- BSX
- 14.12%
- MDT
- 10.65%
- ABT
- 9.14%
- MCK
- --
Net Margin (TTM)
Boston Scientific (BSX) keeps 16.62% of revenue as net profit, putting net margin in the upper peer quartile. After operating costs, interest, and taxes, more of each sales dollar reaches shareholders than it does at most industry peers.
BSX
Health Care Equipment & Services industry group
16.62%
Group distribution
- Max
- 29.35%
- BSX
- 16.62%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Largest peers
- ISRG
- 25.54%
- BSX
- 16.62%
- MDT
- 13.93%
- SYK
- 13.78%
- ABT
- 9.75%
- UNH
- 3.53%
- MCK
- 1.12%
Operating Margin (TTM)
Boston Scientific (BSX) turns 19.05% of revenue into operating profit, putting operating margin in the upper peer quartile. Before financing and taxes enter the picture, the day-to-day business keeps more of each sales dollar than most industry peers.
BSX
Health Care Equipment & Services industry group
19.05%
Group distribution
- Max
- 35.43%
- BSX
- 19.05%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Largest peers
- ISRG
- 33.29%
- SYK
- 22.96%
- MDT
- 19.33%
- BSX
- 19.05%
- ABT
- 11.66%
- UNH
- 5.82%
- MCK
- 1.48%
Profitability Metrics
| Metric | Current stock: BSX | Industry group median |
|---|---|---|
| ROE (TTM) | 14.12% | 5.45% |
| ROA (TTM) | 5.87% | 3.17% |
| Net Margin (TTM) | 16.62% | 2.18% |
| Operating Margin (TTM) | 19.05% | 6.81% |
| Gross Margin (TTM) | 67.98% | 55.21% |
Growth
Revenue Growth
Boston Scientific (BSX) grew revenue 19.87%, roughly around the peer group's normal range. Top-line momentum looks broadly typical for the industry.
EPS Growth
Boston Scientific (BSX) grew earnings per share 55.20%, in the upper peer quartile. Per-share profits are compounding faster than at most industry peers.
Growth Metrics
| Metric | Current stock: BSX | Industry group median |
|---|---|---|
| Revenue Growth (YoY) | 19.87% | 11.55% |
| Revenue Growth (3Y CAGR) | 16.54% | 10.83% |
| EPS Growth (YoY) | 55.20% | 4.88% |
| EPS Growth (3Y CAGR) | 62.75% | 14.59% |
Financial Strength
Current Ratio (MRQ)
Boston Scientific (BSX) has current ratio of 1.37, in the tighter-liquidity quartile for its industry. The short-term cushion is thinner than most peers carry, even if the absolute comfort level still depends on the business model.
BSX
Health Care Equipment & Services industry group
1.37
Group distribution
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- BSX
- 1.37
- Min
- 0.30
Largest peers
- ISRG
- 3.33
- SYK
- 2.18
- MDT
- 2.07
- ABT
- 1.46
- BSX
- 1.37
- MCK
- 0.90
- UNH
- 0.74
Debt / Equity (MRQ)
Boston Scientific (BSX) has debt-to-equity ratio of 0.46, roughly in line with the peer group’s normal leverage range. Its mix of debt and equity looks typical for the industry.
BSX
Health Care Equipment & Services industry group
0.46
Group distribution
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- BSX
- 0.46
- Q1
- 0.16
- Min
- 0.00
Largest peers
- UNH
- 0.70
- SYK
- 0.66
- ABT
- 0.61
- MDT
- 0.55
- BSX
- 0.46
- ISRG
- --
- MCK
- --
Financial Strength Metrics
| Metric | Current stock: BSX | Industry group median |
|---|---|---|
| Current Ratio (MRQ) | 1.37 | 1.98 |
| Debt / Equity (MRQ) | 0.46 | 0.58 |
| Net Debt / EBITDA | 2.04 | 2.04 |
Dividends
Dividend Yield (TTM)
Boston Scientific (BSX) pays no dividend, leaving dividend yield at 0.00% this period. Shareholders may still receive value through reinvestment or buybacks, but there is no dividend income to compare here.
BSX
Health Care Equipment & Services industry group
0.00%
Group distribution
- BSX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Largest peers
- MDT
- 2.72%
- UNH
- 2.29%
- ABT
- 2.22%
- SYK
- 1.05%
- MCK
- 0.32%
- BSX
- 0.00%
- ISRG
- 0.00%
Dividend Payout Ratio (TTM)
Boston Scientific (BSX) paid no earnings out as dividends this period, leaving payout ratio at 0.00%. There is no dividend payout to size against earnings.
BSX
Health Care Equipment & Services industry group
0.00%
Group distribution
- BSX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Largest peers
- ABT
- 92.54%
- MDT
- 70.02%
- UNH
- 51.71%
- SYK
- 37.49%
- MCK
- 8.77%
- BSX
- 0.00%
- ISRG
- 0.00%
Dividend Metrics
| Metric | Current stock: BSX | Industry group median |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
Boston Scientific (BSX) trades at P/E ratio of 18.04, in the cheaper earnings-multiple quartile for its industry. Investors are paying less for each dollar of TTM earnings than they usually pay for comparable businesses.
BSX
Health Care Equipment & Services industry group
18.04
Group distribution
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- BSX
- 18.04
- Min
- 4.21
Largest peers
- ISRG
- 54.75
- ABT
- 41.02
- SYK
- 34.70
- MCK
- 27.36
- MDT
- 25.01
- UNH
- 22.50
- BSX
- 18.04
P/S Ratio (TTM)
Boston Scientific (BSX) trades at 2.94 on P/S ratio, roughly in the peer group’s normal range. The market is not making a strong cheap-or-rich statement about its revenue base.
BSX
Health Care Equipment & Services industry group
2.94
Group distribution
- Max
- 8.80
- Q3
- 4.32
- BSX
- 2.94
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
Largest peers
- ISRG
- 13.82
- SYK
- 4.72
- ABT
- 3.95
- MDT
- 3.47
- BSX
- 2.94
- UNH
- 0.78
- MCK
- 0.29
P/B Ratio (MRQ)
Boston Scientific (BSX) trades at 2.42 on P/B ratio, roughly in line with the industry’s normal price-to-book range. Its balance sheet is not being priced at a clear discount or premium versus peers.
BSX
Health Care Equipment & Services industry group
2.42
Group distribution
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- BSX
- 2.42
- Q1
- 1.73
- Min
- -1.31
Largest peers
- ISRG
- 9.82
- SYK
- 5.29
- ABT
- 3.73
- UNH
- 3.60
- MDT
- 2.59
- BSX
- 2.42
- MCK
- -30.85
Valuation Metrics
| Metric | Current stock: BSX | Industry group median |
|---|---|---|
| P/E Ratio (TTM) | 18.04 | 29.93 |
| P/S Ratio (TTM) | 2.94 | 2.13 |
| P/B Ratio (MRQ) | 2.42 | 3.00 |
| Free Cash Flow Yield (TTM) | 4.02% | 3.50% |